NuSmile NeoMTA ® Launches in Canada

Breakthrough material is the only affordable MTA specifically optimized for pediatric dentistryHOUSTON, TEXAS, April 6, 2017 —NuSmile Ltd., the worldwide leader in pediatric esthetic restorative dentistry, announced today that its NuSmile NeoMTA is now available in Canada.NuSmile NeoMTA is the first and only affordable MTA specifically optimized for pediatric dentistry. The ideal treatment for pulpotomies, direct and indirect pulp capping, and apexification, it is quickly wash- out resistant, non-staining and has excellent handling properties. NuSmile NeoMTA is also bioactive and non-toxic, delivering peace of mind that formocresol may not provide.Cost-effective for pediatric dentistryHistorically, many dentists who would have preferred to use bioactive, non-toxic MTA rather than formocresol for pediatric pulp therapy found MTA to be cost-prohibitive. This is no longer an issue, as NuSmile NeoMTA ’s cost per gram is dramatically less than that of all other leading MTAs. Moreover, its unique dessicant-lined bulk packaging system allows dentists to use only what is needed for each pulp therapy, virtually eliminating waste.Truly bioactiveUnlike formocresol and resin/MTA blends, NuSmile NeoMTA is bioactive, hydrophilic, non-toxic and 100 percent biocompatible. MTA has been widely studied and is proven to trigger the formation of hydroxyapatite leading to dentinal bridging. NuSmile NeoMTA contains no resins, and thus delivers unmatched performance for pediatric dental procedur...
Source: Dental Technology Blog - Category: Dentistry Source Type: news